Navigation Links
The Bachmann-Strauss Dystonia & Parkinson Foundation: New Study Identifies Gene Mutations as Cause of Dystonia in Amish-Mennonite Families
Date:2/3/2009

Breakthrough findings contribute to better understanding of little-known disease and may lead to development of new therapies

NEW YORK, Feb. 3 /PRNewswire/ -- A new research study has identified mutations in the THAP1 gene as a cause of primary torsion dystonia (DYT6 type) in Amish-Mennonite families and cited a second mutation in a non-Mennonite family showing that THAP1 causes dystonia in other ethnic groups.

A paper entitled "Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia" was published February 1, 2009 on-line in the journal Nature Genetics. Co-investigators on the study are Susan Bressman, MD, chair, Department of Neurology, Beth Israel Medical Center, and Laurie Ozelius, PhD, Associate Professor, and Bachmann-Strauss Professor, Mount Sinai School of Medicine, New York City.

This new body of research also revealed that the THAP1 gene has DNA binding and apoptosis (or cell death) functions, neither of which were previously associated with primary torsion dystonia. In addition it showed that the mutations in THAP1 can impair DNA binding. The protein encoded by THAP1 is predicted to bind DNA near the start site of other genes and then turn on or off the expression of those genes. Since there are a number of factors that come into play in addition to this "transcription factor", a mutation that impairs DNA binding could upset that balance and, as a consequence, turn other genes on or off, contributing to dystonia.

"The DNA binding function attributed to this gene has not previously been associated with dystonia. The discovery of this gene could help us develop new treatments in the future to prevent this debilitating disease," said Dr. Ozelius.

This is the second gene identified for primary torsion dystonia. The first, discovered ten years ago, was the DYT1 gene which was found to be mutated in most people with early onset dystonia. While people may carry the DYT1 or THAP1 genes, they may not show clinical symptoms, suggesting that other genes or environmental factors also play a role in these diseases.

"We are thrilled by these new findings, which should open up the science in many different ways," said Dr. Bressman. "Studies are underway to determine the role of THAP1 in other families and populations. Based on the families we identified, dystonia due to DYT6 is similar to DYT1 in that it starts in childhood and can affect many muscles but, unlike DYT1, people who have the DYT6 mutation are more likely to have problems in the lower face, jaw and vocal cords."

Dystonia is a neurological muscle disorder that causes uncontrollable, painful spasms in one or more parts of the body. It strikes an estimated 500,000 people in North America alone, affecting more people than muscular dystrophy, Huntington's disease and Lou Gehrig's disease combined.

The Bachmann-Strauss Dystonia & Parkinson Foundation provided funding in part for this study and for the earlier discovery of the DYT1 gene.

"This impressive discovery will play an important role in furthering our understanding of this terrible disease," said Bonnie Strauss, president and founder of the organization.

Established in 1995 to find better treatments and cures for the movement disorders, dystonia and Parkinson's disease, The Bachmann-Strauss Dystonia & Parkinson Foundation is an independent, nonprofit, 501(c)3 organization. Its funding is made possible through the generosity of individual and corporate contributors.


'/>"/>
SOURCE The Bachmann-Strauss Dystonia & Parkinson Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Stimulating muscles may improve musicians dystonia
2. Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor
3. Decreased activity of basal ganglia is the main cause of abnormal muscle constrictions in dystonia
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Gene Mutation Linked to Parkinsons Disease
6. Parkinsons Linked to Risk of Alzheimers
7. XShares Supports Parkinsons Disease Foundation 50th Anniversary Educational Symposium
8. Parkinsons Institute research shows that nicotine reduces levodopa-induced dyskinesias
9. NSAIDs Protect Against Parkinsons Disease
10. Ceregene Completes Enrollment of Phase 2 Clinical Trial for Parkinsons Disease
11. Relatives of Parkinsons Patients at Higher Psychiatric Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... MA (PRWEB) , ... June 20, 2017 , ... Kenneth ... International AIDS Society (JIAS). , Dr. Mayer, who joined the JIAS Editorial Board ... is the founding Medical Research Director of Fenway Health and Co-Chair of ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... HOUSTON – ... new website and a host of new options for today’s modern senior. Brazos ... maintain the active, independent lifestyle they love while offering them the services to support ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... content solutions for the enterprise, is proud to announce Touchpoints integrations. ... ticketing systems, company websites, and more to provide a seamless customer experience. , ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... in Cincinnati, OH for leading-edge care, whether or not they have a ... Using the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and damaged tissue without ...
(Date:6/20/2017)... ... ... With certifications and experience that puts them at the top of the ... are currently accepting new patients at their practice for these custom clear aligners. These ... is why they offer the latest in modern dental techniques to ensure that all ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
(Date:5/26/2017)... 2017  In response to the opioid epidemic in ... is working with Pfizer to make up to 1 ... to community health centers, free and charitable clinics, public ... "Pfizer has a long-standing commitment to improving health ... safety through educational activities," said Caroline Roan , ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, ... Gene-Eden-VIR/Novirin, announces the launch of a new ... the results of a clinical study that showed ... treatment with Gene-Eden-VIR/Novirin in individuals suffering from HPV ... note that there are no other treatments that ...
Breaking Medicine Technology: